Back to SYRE

WESTFIELD CAPITAL MANAGEMENT CO LP → SYRE

WESTFIELD CAPITAL MANAGEMENT CO LP SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
1
Latest value
$78.7M
Q3 2026
Peak value
$78.7M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$78.7M883.9K——

Other funds holding SYRE

Other WESTFIELD CAPITAL MANAGEMENT CO LP positions

NVDA

NVIDIA CORPORATION

$1.8B
NVDA

NVIDIA CORPORATION

$1.6B
GOOGN

ALPHABET INC

$1.4B
GOOGN

ALPHABET INC

$1.3B
ASND

ASCENDIS PHARMA A/S

$1.3B
ASND

ASCENDIS PHARMA A/S

$1.2B
NVDA

NVIDIA CORPORATION

$1.1B
ASND

ASCENDIS PHARMA A/S

$1.1B